Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01121263 · ClinicalTrials.gov registry record

Hybrid Revascularization Observational Study

A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
298
Enrollment target

NCT01121263: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT01121263 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 298 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01121263 has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
298 participants
Enrollment target

Study Summary

The purpose of the study is to get a better understanding of patients who have multi-vessel coronary artery disease (blockages in more than one vessel bringing blood to the heart) and have either Hybrid Coronary Revascularization \[HCR\] (combination of surgery and catheter procedures to open up clogged heart arteries) or Percutaneous Coronary Intervention \[PCI\] (catheter procedures to open up clogged heart arteries). Participation in the study will last up to 21 months after a patient's heart procedure(s). The study collects information about the medical care patients receive during their planned procedure(s) and how well they do following the procedure(s). No new testing or procedures will be done. Patients will receive only the tests or procedures their doctor already has planned for them. The information collected should help to plan the design of a pivotal comparative effectiveness study of hybrid revascularization.

Primary Outcome

For the purposes of this study MACCE is defined as a non-weighted composite score comprised of the following components: * Death * Stroke * Myocardial Infarction * Repeat Revascularization

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2010-05
Est. Completion 2013-08

What the finished NCT01121263 record still lists

NCT01121263 is an observational study that tracks outcomes without assigning an intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01121263 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01121263 about?

NCT01121263 is a clinical study titled "Hybrid Revascularization Observational Study". The purpose of the study is to get a better understanding of patients who have multi-vessel coronary artery disease (blockages in more than one vessel bringing blood to the heart) and have either Hybrid Coronary Revascularization \[HCR\] (combination of surgery and catheter procedures to open up clo...

What is the current status of trial NCT01121263?

This trial is currently completed. The enrollment target is 298 participants. The study started on 2010-05. Estimated completion is 2013-08.

Who is sponsoring clinical trial NCT01121263?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06305624 · 298 participants · NA

    Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

  • NCT06754215 · 298 participants · NA

    Smoking Cessation Intervention Development for Homeless Youth

  • NCT06780111 · 298 participants · Phase 1

    Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

  • NCT07209358 · 298 participants · NA

    EDX110 Randomized Control Trial for Treatment of DFUs

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01121263, the US trial registry maintained by the National Library of Medicine. NCT01121263 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.